HYdroxychloroquine to Improve Pregnancy Outcome in Women With AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine Versus Placebo in Addition to Standard Treatment in Pregnant Women With Antiphospholipid Syndrome or Antibodies
Seminars in Thrombosis and Hemostasis - United States
doi 10.1055/s-0037-1603359
Full Text
Open PDFAbstract
Available in full text
Date
June 13, 2017
Authors
Publisher
Georg Thieme Verlag KG